Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 14 2024
0mins
Source: PRnewswire
Merger Announcement: Kintara Therapeutics has set a record date of October 17, 2024, for issuing Contingent Value Rights (CVRs) to its stockholders in connection with its merger with TuHURA Biosciences, expected to close on October 18, 2024, pending regulatory approval.
Reverse Stock Split: Kintara plans to implement a reverse stock split at a ratio of 1-for-35 immediately before the merger, following stockholder approval for a range of 1-for-20 to 1-for-40 during a special meeting held on October 4, 2024.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
